| 产品名称 | Quartett C-O001/P-O001 | Olig2 (QR071) |
|---|---|
| 目录号 | C-O001/P-O001 |
| 别名 | Olig2 |
| 外观 | 见COA |
| 分子量 | |
| CAS | |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
Quartett C-C031/P-C031 | CD31 (QR034)
品名:Olig2 (QR071) | Recombinant monoclonal rabbit antibody
货号:C-O001/P-O001
品牌:Quartett
规格:0.1 ml; 0.5 ml; 1 ml; 3 ml; 7 ml; 15 ml
产品描述
| Application | IHC (FFPE) | Host | Rabbit |
| Subclass | IgG | Dilution range | 1:100 – 1:200 |
| Cellular localization | Nucleus | Control | Astrocytoma |
| Immunogen | Synthetic peptide from human Olig2 | ||
Olig2 is a transcription factor involved in oligodendroglial specification. It is expressed in most glial tumors, such as oligodendrogliomas and astrocytomas, but has not been detected in non-glial tumors such as neuroepithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid/rhabdoid tumors, and hemangioblastomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak, both in terms of the percentage of labeled cells and its intensity. Compared to the strong staining in glioma samples, expression in non-tumorous brain tissue is weak.